Detalhe da pesquisa
1.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study.
Am J Respir Crit Care Med;
2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38635834
2.
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
Eur Heart J;
42(37): 3844-3852, 2021 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34269376
3.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol;
22(11): 1530-1540, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34656227
4.
A novel approach to welfare interventions in problem multi-cat households.
BMC Vet Res;
15(1): 434, 2019 Dec 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31796018
5.
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
BMJ Open;
13(11): e073120, 2023 11 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37993149